EUVIMEDEUVIMED entdecken
Crossref

Reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD"

Moon Haeng Hur, Hyunjae Shin, Yoon Jun Kim

Clinical and Molecular Hepatology · 05.11.2026

DOI: 10.3350/cmh.2026.0471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 05.11.2026. Verfasst von Moon Haeng Hur und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AspirinFatty liverLiver cancerUK Biobank

Autor:innen und Institutionen

  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine. yoonjun@snu.ac.kr.

Zitieren

APA

Hur, M. H., Shin, H., & Kim, Y. J. (2026). Reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD". Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0471

Vancouver

Hur MH, Shin H, Kim YJ. Reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD". Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0471

BibTeX
@article{Hur2026,
  author = {Hur, Moon Haeng and Shin, Hyunjae and Kim, Yoon Jun},
  title = {Reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD"},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0471}
}
Kostenlos starten →